Analyst Ratings

Date	Action	Analyst	Rating	Target
May-28-26	Reiterated	H.C. Wainwright		$35 → $32
May-28-26	Downgrade	HC Wainwright & Co.	Buy → Neutral
May-08-26	Downgrade	Citigroup	Buy → Neutral
May-07-26	Reiterated	Stephens		$32
May-07-26	Downgrade	Stephens & Co.	Overweight → Equal Weight
Nov-07-25	Reiterated	Oppenheimer	Outperform	$32 → $33
Mar-03-25	Reiterated	Robert W. Baird		$28 → $32
Feb-04-25	Initiated	Baird	Outperform	$28
Jan-10-25	Reiterated	H.C. Wainwright		$30 → $35
Dec-21-22	Reiterated	Truist Financial		$17 → $18

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023
Total Revenue	597	589	492	Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A	105	87	69
Gross Profit	492	502	423
Selling, General and Administrative Excl. Other	195	194	178
Research and Development	12	13	13
Other Operating Expense	17	37	37
Operating Income	267	258	195
Interest Expense	0	0	0
Unusual Expense	—	—	—
Non-Operating Income (Expense)	-29	-26	-21
Net Income Before Taxes	296	284	216
Income Taxes	74	69	52
Consolidated Net Income	222	214	164
Net Income From Continuing Operations	222	214	164
Net Income	222	214	164
EPS (Recurring)	1.80	1.75	1.38
EPS (Basic, Before Extraordinaries)	1.80	1.75	1.38
EPS (Diluted)	1.73	1.68	1.31
EBITDA	334	321	254
Other After Tax Adjustments	—	—	—
Stock Option Compensation Expense	—	—	—
Price To Earnings Ratio	18.14	13.89	—
Price To Sales Ratio	6.41	4.83	—
Gross Margin	82.41	85.23	85.98
Operating Margin	44.72	43.80	39.63
Net Margin	37.19	36.33	33.33
Shares Outstanding	122	122	118
Market Capitalization	3,828	2,847	—
Operating Lease Expense	—	—	—

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Andrews William T.	Chief Medical Officer	Jun 03 '26	Option Exercise	0.00	3,052	0	3,052	Jun 05 12:00 AM
Andrews William T.	Chief Medical Officer	Jun 03 '25	Option Exercise	0.00	3,052	0	240,195	Jun 05 12:00 AM
Russo Gregg	Chief HR Officer	Feb 17 '26	Option Exercise	0.00	1,374	0	71,786	Feb 19 12:00 AM
Daly Richard J	President and CEO	Jan 05 '26	Option Exercise	0.00	84,210	0	2,618,539	Jan 06 12:00 AM
Kalb Michael Wayne	Executive Vice President & CFO	Jan 05 '26	Option Exercise	0.00	14,278	0	632,903	Jan 06 12:00 AM
Miller Steve	Chief Op. & Scientific Officer	Dec 29 '25	Option Exercise	0.00	28,000	0	1,471,649	Dec 30 12:00 AM
Harper Molly	Director	Dec 29 '25	Option Exercise	0.00	2,668	0	127,163	Dec 30 12:00 AM
MCENANY PATRICK J	director, other: Chairman of Board of Directors	Dec 29 '25	Option Exercise	0.00	52,668	0	4,178,345	Dec 30 12:00 AM
Daly Richard J	President and CEO	Dec 29 '25	Option Exercise	0.00	2,668	0	2,660,644	Dec 30 12:00 AM
Del Carmen Jeffrey	Chief Commercial Officer	Dec 29 '25	Option Exercise	0.00	17,334	0	1,036,846	Dec 30 12:00 AM
DENKHAUS DONALD A	Director	Dec 29 '25	Option Exercise	0.00	2,668	0	498,773	Dec 30 12:00 AM
Elsbernd Brian	Chief Compliance/Legal Officer	Dec 29 '25	Option Exercise	0.00	13,334	0	956,142	Dec 30 12:00 AM
Tierney David S	Director	Dec 29 '25	Option Exercise	0.00	2,668	0	383,314	Dec 30 12:00 AM
Sundaram Preethi	Chief Strategy Officer	Dec 29 '25	Option Exercise	0.00	13,334	0	798,437	Dec 30 12:00 AM
Harper Molly	Director	Dec 12 '25	Option Exercise	5.78	40,000	231,200	128,497	Dec 16 12:00 AM


Market Cap	3.84B	Forward P/E	14.01	EPS next Y	2.24	Insider Trans	0.19%	Shs Float	-	Perf Month	0.54%


Enterprise Value	3.09B	PEG	2.06	EPS next Q	0.67	Inst Own	-	Short Float	-	Perf Quarter	40.53%


Income	221.80M	P/S	6.44	EPS this Y	11.13%	Inst Trans	-	Short Ratio	-	Perf Half Y	29.72%


Sales	596.96M	P/B	3.79	EPS next Y	16.51%	ROA	19.29%	Short Interest	-	Perf YTD	34.45%


Book/sh	8.28	P/C	18.44	EPS next 5Y	8.86%	ROE	23.65%	52W High	32.56 -3.62%	Perf Year	35.14%


Cash/sh	6.18	P/FCF	18.47	EPS past 3/5Y	-	ROIC	19.67%	52W Low	19.05 64.72%	Perf 3Y	-


Dividend Est.	-	EV/EBITDA	9.23	Sales past 3/5Y	40.14% 37.69%	Gross Margin	82.32%	Volatility	0.07% 0.14%	Perf 5Y	-


Dividend TTM	-	EV/Sales	5.18	EPS Y/Y TTM	112.21%	Oper. Margin	44.83%	ATR (14)	0.18	Perf 10Y	-


Dividend Ex-Date	-	Quick Ratio	6.84	Sales Y/Y TTM	21.34%	Profit Margin	37.08%	RSI (14)	71.61	Recom	2.75


Dividend Gr. 3/5Y	-	Current Ratio	7.10	EPS Q/Q	8.82%	SMA20	0.21%	Beta	0.72	Target Price	31.75


Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	5.67%	SMA50	5.66%	Rel Volume	1.30	Prev Close	31.40


Employees	181	LT Debt/Eq	0.00	Earnings	Aug 05	SMA200	28.45%	Avg Volume	2.47M	Price	31.38


IPO Date	Nov 08, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	15.63% -0.67%	Net Debt/EBITDA	-2.25	Volume	3,211,605	Change	-0.06%

CPRX